Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Clinical trial NCT07552558 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07552558
Sponsor: Washington University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma HPV-Negative Squamous Cell Carcinoma

Start date: 2026-09-30
Primary completion: 2028-11-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.